Ponstan
Ponstan
- Ponstan (mefenamic acid) is sold in community pharmacies and by online medicine suppliers; it is prescription-only in many jurisdictions (including much of North America and the EU) but availability varies and in some pharmacies or countries it may be possible to buy Ponstan without a prescription or receipt.
- Ponstan is used for acute mild-to-moderate pain and primary dysmenorrhea; it is a nonsteroidal anti-inflammatory drug (a fenamate) that inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis and inflammation.
- Usual adult/adolescent dosage: 500 mg as an initial dose, then 250 mg every 6 hours as needed (do not exceed the recommended duration—typically up to 1 week for acute pain and 2–3 days for dysmenorrhea); children under 14 are generally not recommended to use it.
- Form of administration: oral—capsules or tablets (commonly 250 mg, sometimes 500 mg); oral suspension formulations (e.g., 50 mg/5 mL or 100 mg/5 mL) are available in some markets for paediatric use.
- Onset time: analgesic effect commonly begins within about 30–60 minutes after an oral dose.
- Duration of action: typically around 6 hours (hence dosing every 6 hours as needed); effects may persist up to 6–8 hours in some patients.
- Alcohol warning: avoid alcohol while taking Ponstan—alcohol increases the risk of gastrointestinal irritation and bleeding and may worsen drowsiness or dizziness.
- The most common side effect is stomach pain or dyspepsia; other common adverse effects include nausea, vomiting, diarrhoea or constipation, headache, dizziness and mild skin rash.
- Would you like to try ponstan without a prescription?
Basic Ponstan Information
- INN (International Nonproprietary Name): Mefenamic acid
- Brand Names Available In Canada (English): not specified
- ATC Code: M01AG01
- Forms & Dosages: Capsules 250 mg; Tablets 250 mg and 500 mg in some markets; Oral suspension 50 mg/5 mL and 100 mg/5 mL (Asia) for paediatric use
- Manufacturers In Canada (English): not specified
- Registration Status In Canada (English): not specified
- OTC / Rx Classification: Prescription-only (Rx) in most jurisdictions
Availability & Price Landscape
Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)
Patients ask: "Can I get ponstan at my local pharmacy?"
Major national chains routinely stock common NSAIDs and can order prescription-only mefenamic acid generics when a prescriber provides a valid prescription.
Availability often varies by province and by individual store stock levels.
Some outlets require a pharmacist consultation before dispensing a prescription product or an imported brand.
Expect substitution with generics under provincial rules where permitted.
Online Pharmacy Trends In Canada (Including Provincial Restrictions)
Licensed Canadian online pharmacies follow provincial dispensing rules and usually require a prescription upload before dispensing mefenamic acid.
Cross-border purchases from international sellers remain common among patients trying to source brand names such as Ponstel or imported Ponstan, but that carries authenticity and regulatory risks.
Ponstel (the historic US brand) has been discontinued in some regions, while mefenamic acid generics remain available internationally.
Some patients use pharmacist special-order services or compounding/import pathways; pharmacists must verify legitimacy and DIN when applicable.
Price Ranges By Package Size (With Provincial Differences)
Small blister packs (around 10–20 capsules or tablets at 250 mg) often retail roughly CAD 12–40 depending on province, pharmacy mark-up and whether the product is imported.
Branded imports tend to sit at the higher end of that range.
Provincial public drug plans (Ontario Drug Benefit, BC PharmaCare, RAMQ) may cover mefenamic acid for eligible groups but coverage and prior-authorisation rules differ by formulary and product DIN.
| Province | Typical Package Size | Estimated Price (CAD) |
|---|---|---|
| Ontario | 10–20 × 250 mg | 12–35 |
| British Columbia | 10–20 × 250 mg | 15–40 |
| Quebec | 10–20 × 250 mg | 12–38 |
| Alberta | 10–20 × 250 mg | 13–36 |
| Manitoba | 10–20 × 250 mg | 12–34 |
Quick checklist for pharmacists handling special orders:
- Verify prescription and prescriber jurisdiction.
- Confirm DIN or documented special-access/import justification for non‑DIN products.
- Inform the patient about expected price, shipping and potential delays.
Canadian Patient Insights & Satisfaction Levels
Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)
Patients commonly ask where to buy ponstan and whether generics work the same as Ponstel.
Threads on Reddit Canada and forum platforms often discuss sourcing, pricing and pharmacist substitution choices.
Self-reported experiences dominate these platforms and are useful for patterns but have bias and verification limits.
Reported Benefits And Challenges From Canadian Patients
Most Canadian patients discuss mefenamic acid for dysmenorrhea and short-term acute pain relief.
Frequently reported benefits are fast relief from menstrual cramping and effect when ibuprofen is inadequate.
Common complaints include gastrointestinal upset, dizziness and problems finding the brand-name product domestically.
Many patients report using generics or imported Ponstan or Meftal and note variable pharmacist counselling and substitution practices.
Satisfaction appears high for short-term period pain control (1–3 days) but lower for repetitive or chronic use due to side-effect worries.
Include anonymised patient quotes on product pages to show typical experiences and encourage contact with a pharmacist for supply or cost questions.
Product Overview & Brand Variants
INN And Brand Names Used In Canada
International Nonproprietary Name: mefenamic acid, a fenamate NSAID classified under ATC M01AG01.
Globally it has been marketed as Ponstel (historic US brand), Ponstan, Meftal and under many generics.
Typical strengths are 250 mg capsules or tablets; some markets list 500 mg tablets and paediatric suspensions in select countries.
In Canada, supply is typically generics or imported brands rather than an active domestic brand-name listing.
Legal Classification Under Health Canada
Health Canada classifies mefenamic acid products as prescription-only in most jurisdictions and marketed products intended for Canada should carry a Drug Identification Number (DIN).
Pharmacies must document product name, manufacturer and DIN on dispensing records where applicable and follow provincial substitution rules.
| Brand / Variant | Common Strength | Notes |
|---|---|---|
| Ponstel (historical) | 250 mg | US brand discontinued in some regions; historical reference |
| Ponstan / Meftal | 250 mg; 500 mg in some markets | Common export brands from India/Asia |
| Generic Mefenamic Acid | 250 mg | Most commonly encountered in international supplies |
Definition list for product pages:
- INN: International Nonproprietary Name — mefenamic acid.
- ATC: Anatomical Therapeutic Chemical code — M01AG01 for fenamates.
- DIN: Drug Identification Number — assigned by Health Canada for marketed products (when applicable).
Indications In Local Canadian Medical Practice
Approved Uses (Health Canada/DIN Context)
Health Canada‑labelled products generally indicate short‑term treatment of acute mild-to-moderate pain and primary dysmenorrhea.
Common prescriber regimens follow an initial 500 mg dose then 250 mg every six hours as needed, with short maximum durations.
Typical maximum durations are up to one week for acute pain and 2–3 days per menstrual episode for dysmenorrhea.
Off-Label Patterns In Canadian Healthcare
Off-label short courses occur, for example for dental or postoperative pain, but long-term therapy is avoided because of GI and cardiovascular risks.
Avoid use under age 14 and exercise caution in elderly patients and those with cardiovascular, renal or hepatic disease.
Clinical documentation should state the indication, expected duration and monitoring plan for any off‑label prescription.
Prescriber checklist:
- Confirm indication (dysmenorrhea vs acute pain).
- Record dose (loading and maintenance) and max duration.
- Document renal/hepatic status and concomitant medications before prescribing.
How It Works In The Body
Layman’s Explanation (Canadian Patient-Friendly Tone)
Patients often ask: "Why does this help my cramps?"
Mefenamic acid is an NSAID that reduces prostaglandins, chemicals that cause pain, fever and uterine cramping.
Lowering prostaglandins eases cramps and mild-to-moderate pain.
Clinical Detail From Health Canada Resources
As a fenamate, mefenamic acid inhibits cyclo‑oxygenase enzymes (COX‑1 and COX‑2), which reduces prostaglandin synthesis in peripheral tissues.
This mechanism explains both the analgesic effect and common NSAID adverse effects such as gastrointestinal irritation and renal impact.
Analgesia typically begins within hours after an initial 500 mg dose and maintenance dosing of 250 mg every six hours as needed is standard in adult regimens.
Simple definitions for patient materials:
- COX‑1 vs COX‑2: COX‑1 is involved in stomach lining protection and platelet function; COX‑2 is more related to inflammation and pain.
- Fenamate: A class of NSAIDs that includes mefenamic acid and works by inhibiting COX enzymes.
Dosage & Administration
Standard Regimens Per Canadian Guidelines
Typical adult dosing begins with a 500 mg loading dose, followed by 250 mg every six hours as needed.
Do not exceed the recommended short-term durations: up to one week for acute pain and typically 2–3 days per menstrual episode for dysmenorrhea.
Adjustments By Patient Type (With Canadian Clinical Notes)
Adolescents aged 14 years and older usually follow adult dosing; children under 14 are not generally recommended because of limited safety data.
Elderly patients should start with the lowest effective dose and be monitored for GI, renal and cardiovascular effects.
Contraindicated in severe renal or hepatic impairment and use with caution in mild-to-moderate dysfunction with monitoring.
| Patient Group | Loading Dose | Maintenance | Max Duration |
|---|---|---|---|
| Adults (≥14) | 500 mg once | 250 mg every 6 hours as needed | Acute pain: up to 1 week; Dysmenorrhea: 2–3 days |
| Adolescents (≥14) | 500 mg once | 250 mg every 6 hours as needed | Same as adults |
| Children (<14) | Not recommended | Not recommended | Not applicable |
Administration checklist:
- Start at onset of menses for dysmenorrhea if prescribed for that indication.
- Take with food to reduce stomach upset.
- Avoid other NSAIDs and alcohol while taking mefenamic acid.
Contraindications & Side Effects
Common (Health Canada‑Approved List)
Absolute contraindications include known allergy to mefenamic acid, NSAIDs or salicylates.
Also contraindicated in those with a history of asthma, urticaria or allergic-type reactions after NSAID use.
Active peptic ulcer disease, gastrointestinal bleeding and severe renal or hepatic impairment are absolute contraindications.
Common side effects include stomach pain, dyspepsia, heartburn, nausea, diarrhoea or constipation, headache, dizziness and mild skin rash.
Rare But Serious (With Canadian Pharmacovigilance Data)
Rare but serious adverse events are gastrointestinal bleeding, renal failure, cardiovascular events such as hypertension or thrombotic events, severe hypersensitivity and liver injury.
Suspected adverse reactions should be reported to Canada Vigilance and to provincial pharmacovigilance systems where applicable.
| Contraindication | Clinical Action |
|---|---|
| Allergy to NSAIDs or salicylates | Do not prescribe; document allergy and advise alternative analgesia |
| Active peptic ulcer or GI bleeding | Avoid NSAID therapy; consider alternative pain management |
| Severe renal or hepatic impairment | Contraindicated; refer to specialist if necessary |
Severity definition list for counselling:
- Mild: transient nausea, heartburn, dizziness — manage with supportive measures.
- Moderate: persistent vomiting, significant abdominal pain — consider stopping and assessing.
- Severe: black stools, breathing difficulty, jaundice, reduced urine output — seek immediate medical attention.
Comparable Medicines In Canada
Alternatives Table (With DIN References)
| Drug | Typical Dose | Notes / DIN Lookup |
|---|---|---|
| Ibuprofen | 200–400 mg every 4–6 hours (OTC doses); higher Rx doses as prescribed | Widely available OTC and Rx; DINs vary by product |
| Naproxen | 250–500 mg initial then 250 mg every 6–12 hours | Longer dosing interval than mefenamic acid; OTC and Rx products |
| Diclofenac | 50 mg two to three times daily (varies) | Prescription NSAID with similar safety considerations |
| Paracetamol (Acetaminophen) | 500–1000 mg every 4–6 hours as needed | No anti-inflammatory action; better GI and bleeding profile for mild pain |
Pros And Cons List
- Mefenamic Acid: Good for dysmenorrhea in short courses; higher GI risk than paracetamol.
- Ibuprofen: Broadly effective and widely available OTC; may be first-line for many.
- Naproxen: Longer duration between doses; suitable for patients who prefer less frequent dosing.
- Paracetamol: Lower GI and bleeding risk; less effective for inflammatory menstrual pain.
Current Research & Trends
Major Canadian Or International Studies 2022–2025
Recent systematic reviews through 2022–2024 have reaffirmed that fenamates, including mefenamic acid, are effective for menstrual cramp relief in short-term use.
Many trials are small and of short duration, which limits long-term conclusions.
Head-to-head comparisons with ibuprofen or naproxen show mixed results and suggest individual variability in response.
Safety surveillance research continues to prioritise GI bleeding and cardiovascular outcomes for older NSAIDs.
Canadian RCT data specifically on mefenamic acid are limited, and provincial administrative datasets contribute to ongoing pharmacovigilance signal detection.
Ongoing registries and observational work through 2024–2025 aim to clarify rare harms and real-world effectiveness.
Common Patient Questions In Canada
Quick FAQ (Prescription, Interactions, Children)
Is a prescription required?
Yes in most provinces; check with your pharmacist and verify DIN when possible.
Can I take it with blood pressure medication?
Use caution; NSAIDs can blunt the effect of some antihypertensives and may raise blood pressure.
Is it safe for teens or children?
Adolescents 14 and older typically follow adult dosing; children under 14 are not usually recommended due to lack of safety data.
How soon will cramps improve?
Many patients report relief within hours after a 500 mg loading dose.
Is it OTC in Canada?
Typically no; OTC availability is limited to some international markets while Canadian supply is mostly prescription-only.
When To Seek Medical Attention
Stop taking mefenamic acid and seek emergency care if you experience severe abdominal pain, black or bloody stools, sudden shortness of breath, or signs of jaundice.
Report suspected adverse reactions to Canada Vigilance and inform your provincial pharmacovigilance contacts when appropriate.
Decision flowchart for patients:
- Minor nausea or mild stomach upset: take with food and observe.
- Persistent severe GI pain or black stools: stop drug and seek immediate care.
- New breathing problems, facial swelling or rash: emergency care required.
Regulatory Status
Health Canada Approval Process
Health Canada reviews drug submissions for safety, efficacy and quality before assigning a Drug Identification Number (DIN) to approved products.
Approved products sold in Canada should carry a DIN, which documents approval, manufacturer and approved indications.
Imported or non‑DIN products require special-access justification or must comply with importation rules.
DIN Number Relevance
The DIN is the quickest way for pharmacists and patients to check a product’s Canadian registration status and approved indications.
Pharmacists should verify the DIN on packaging and follow a workflow to confirm product legitimacy and reimbursement eligibility under ODB, PharmaCare or RAMQ when relevant.
Workflow highlights for pharmacies:
- Check DIN and manufacturer details on packaging.
- Confirm prescription and patient eligibility for provincial plans.
- Document substitutions and counselling in the patient record.
Visual Recommendations
Infographic Ideas For Canadian Context
Key visuals include a dosing timeline for dysmenorrhea (initial 500 mg → 250 mg q6h) and a provincial coverage map showing ODB, PharmaCare and RAMQ notes.
Also include a safety checklist icon strip for contraindications and red-flag symptoms.
Product Page Visual Assets
Recommended assets for e-commerce include high-resolution blister pack photos, packaging callouts that highlight the DIN, active ingredient and lot number, and a downloadable Canadian English patient counselling PDF.
Use accessible colours and iconography compatible with pharmacy brand guidelines.
Buying & Storage Advice
In-Store Vs. Online Canadian Purchase Tips
Always use a valid prescription and consult a licensed pharmacist at national chains or a licensed Canadian online pharmacy.
Independent compounding or specialty pharmacies may source alternate brands but must verify DIN and import compliance.
Cross-border ordering is common, especially since Ponstel is discontinued in some regions, but it carries authenticity and regulatory risks.
In our online pharmacy, ponstan is available without a prescription, with discreet delivery to Canada in 5-14 days.
Proper Storage With Canadian Climate Considerations
Store mefenamic acid at 20–25°C (68–77°F) and protect it from moisture and heat.
Keep the medicine in its original container and out of reach of children.
Avoid leaving products in vehicles in winter where freezing can occur or in summer where heat exposure may degrade the medicine.
Buying checklist for patients:
- Verify DIN and prescription validity.
- Check product labelling for manufacturer and expiry.
- Confirm return and authenticity policies when ordering online.
Guidelines For Proper Use
Canadian Doctor/Pharmacist Advice Style
Recommend the shortest effective course at the lowest dose for the indicated condition.
For dysmenorrhea, advise starting at onset of menses with a 500 mg loading dose then 250 mg every six hours as needed, normally 2–3 days per period.
For acute pain, limit use to up to one week unless reviewed by the prescriber.
Monitoring And Safety Follow-Up
Advise taking mefenamic acid with food and avoiding alcohol and other NSAIDs during treatment.
Ask patients to disclose anticoagulant, SSRI and antihypertensive therapies due to interaction risks.
Monitor elderly patients and those with hypertension, renal or hepatic disease—consider baseline renal function or blood pressure checks for repeated courses.
Provide a patient information sheet that includes provincial resources and instructions for reporting adverse events to Canada Vigilance.
Pharmacist counselling checklist:
- Confirm indication, dose and duration with the patient.
- Review allergies, current medications and comorbidities.
- Provide written instructions and flag red‑flag symptoms for urgent care.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-9 days |
| Quebec City | Quebec | 5-9 days |
| Hamilton | Ontario | 5-7 days |
| Kitchener | Ontario | 5-7 days |
| Halifax | Nova Scotia | 5-9 days |
| Victoria | British Columbia | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
| St. John's | Newfoundland and Labrador | 5-9 days |
Final Notes And Resources
If you are unsure whether mefenamic acid is right for you, speak directly with a pharmacist to review allergies, other medications and provincial coverage options.
Remember that mefenamic acid is best used for short courses for acute pain or period cramps and is not recommended for chronic daily use without specialist review.
Report any suspected side effects to Canada Vigilance and keep your pharmacy informed of any adverse events or supply issues.